Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea

Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea

US Patent 11213539 · Granted Jan 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nemolizumab in the treatment of atopic dermatitis with moderate to severe excori2025
Secondary retention device for transit door2018
Combination of a MC1R receptor agonist and UVB for the treatment and/or preventi2017
Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for2016
Maintenance therapy regime/regimen for the treatment of acne2015
Concurrent therapy regime/regimen for the treatment of acne related diseases2014